INNV
Get informed when a big investor buys or sells
+ FollowOvervalued by 126.6% based on the discounted cash flow analysis.
| Market cap | $1.30 Billion |
|---|---|
| Enterprise Value | $1.29 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | 0.39 |
| Outstanding Shares | 135,812,522 |
| P/E Ratio | -461.35 |
|---|---|
| PEG | 39.92 |
| Price to Sales | 1.36 |
| Price to Book Ratio | 9.55 |
| Enterprise Value to Revenue | 1.33 |
| Enterprise Value to EBIT | 28.7 |
| Enterprise Value to Net Income | -59 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.37 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 13.70% |
|---|---|
| Total Invested | $155,311▼ 99.93% |
| Investors Holding | 1▼ 109.00% |
No data
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Its mission is to enable seniors to age independently in their own homes for as long as possible. Its patient-centered care model meaningfully improves...